Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling. | Stem Cell Res Ther | 2021 | 34717747 | PubTator, text mining | PubMed |
| Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. | Medicine (Baltimore) | 2021 | 34713835 | PubTator, text mining | PubMed |
| Newer Horizon of Mesenchymal Stem Cell-Based Therapy in the Management of SARS-CoV-2-Associated Mucormycosis: A Safe Hope for Future Medicine. | Front Microbiol | 2021 | 34707590 | PubTator, text mining | PubMed |
| Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers. | Cancer Biol Med | 2021 | 34697935 | PubTator, text mining | PubMed |
| Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy. | Oncogenesis | 2021 | 34697289 | PubTator, text mining | PubMed |
| Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth. | J Immunother Cancer | 2021 | 34697217 | PubTator, text mining | PubMed |
| Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes. | Front Cell Dev Biol | 2021 | 34692692 | PubTator, text mining | PubMed |
| Pembrolizumab in endometrial cancer: Where we stand now. | Oncol Lett | 2021 | 34691248 | PubTator, text mining | PubMed |
| The potential role of human HIV-1 TAT-Interactive Protein 2 levels in the pathogenesis of contact dermatitis | Turk J Med Sci | 2021 | 34688245 | PubTator, text mining | PubMed |
| RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer. | Pharmaceutics | 2021 | 34683988 | PubTator, text mining | PubMed |
| Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. | Cancers (Basel) | 2021 | 34680266 | PubTator, text mining | PubMed |
| The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 34680245 | PubTator, text mining | PubMed |
| Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma. | Front Oncol | 2021 | 34676164 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers. | Front Immunol | 2021 | 34675941 | PubTator, text mining | PubMed |
| Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses. | Front Oncol | 2021 | 34660294 | PubTator, text mining | PubMed |
| B7-H4 Expression in Precancerous Lesions of the Uterine Cervix. | Biomed Res Int | 2021 | 34651047 | PubTator, text mining | PubMed |
| A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma. | Front Cell Dev Biol | 2021 | 34650975 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of PSMB8. | Sci Rep | 2021 | 34650125 | PubTator, text mining | PubMed |
| Immunological configuration of ovarian carcinoma: features and impact on disease outcome. | J Immunother Cancer | 2021 | 34645669 | PubTator, text mining | PubMed |
| The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives. | J Clin Med | 2021 | 34640541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=54